Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus.
Canonica GW, Blasi F, Carpagnano GE, Guida G, Heffler E, Paggiaro P, Allegrini C, Antonelli A, Aruanno A, Bacci E, Bagnasco D, Beghè B, Bonavia M, Bonini M, Brussino L, Caiaffa MF, Calabrese C, Camiciottoli G, Caminati M, Caruso C, Cavallini M, Chieco Bianchi F, Conte ME, Corsico AG, Cosmi L, Costantino M, Costanzo G, Crivellaro M, D'Alò S, D'Amato M, Detoraki A, Di Proietto MC, Facciolongo NC, Ferri S, Fierro V, Foschino MP, Latorre M, Lombardi C, Macchia L, Milanese M, Montagni M, Parazzini EM, Parente R, Passalacqua G, Patella V, Pelaia G, Pini L, Puggioni F, Ricciardi L, Ridolo E, Rolo J, Scichilone N, Scioscia G, Senna G, Solidoro P, Varricchi G, Vianello A, Yacoub MR, Yang B. Canonica GW, et al. Among authors: caminati m. J Allergy Clin Immunol Pract. 2023 Dec;11(12):3629-3637. doi: 10.1016/j.jaip.2023.07.041. Epub 2023 Aug 7. J Allergy Clin Immunol Pract. 2023. PMID: 37558162 Free article. Review.
Effects of sublingual immunotherapy on allergic inflammation: an update.
Yacoub MR, Colombo G, Marcucci F, Caminati M, Sensi L, Di Cara G, Frati F, Incorvaia C. Yacoub MR, et al. Among authors: caminati m. Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):285-91. doi: 10.2174/187152812800958988. Inflamm Allergy Drug Targets. 2012. PMID: 22506880 Review.
Omalizumab management beyond clinical trials: the added value of a network model.
Caminati M, Senna G, Chieco Bianchi F, Marchi MR, Vianello A, Micheletto C, Pomari C, Tognella S, Savoia F, Mirisola V, Rossi A; NEONET Study Group. Caminati M, et al. Pulm Pharmacol Ther. 2014 Oct;29(1):74-9. doi: 10.1016/j.pupt.2014.01.007. Epub 2014 Feb 6. Pulm Pharmacol Ther. 2014. PMID: 24508951
Emerging drugs for allergic conjunctivitis.
Ridolo E, Montagni M, Caminati M, Senna G, Incorvaia C, Canonica GW. Ridolo E, et al. Among authors: caminati m. Expert Opin Emerg Drugs. 2014 Jun;19(2):291-302. doi: 10.1517/14728214.2014.902443. Epub 2014 Mar 25. Expert Opin Emerg Drugs. 2014. PMID: 24661261 Review.
189 results